Pre-therapeutic Sarcopenia among Cancer patients: an Up-to-date Meta-analysis of Prevalence and Predictive Value during Cancer Treatment
AL Couderc, E Liuu, P Boudou-Rouquette, J Poisson… - Nutrients, 2023 - mdpi.com
This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …
Post‐diagnosis adiposity and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis
N Becerra‐Tomás, G Markozannes… - … journal of cancer, 2024 - Wiley Online Library
The adiposity influence on colorectal cancer prognosis remains poorly characterised. We
performed a systematic review and meta‐analysis on post‐diagnosis adiposity measures …
performed a systematic review and meta‐analysis on post‐diagnosis adiposity measures …
[HTML][HTML] Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis
S Knoedler, R Schliermann, L Knoedler… - … journal of surgery, 2023 - journals.lww.com
Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …
Psoas muscle mass index as a predictor of long-term mortality and severity of complications after major intra-abdominal colorectal surgery–A retrospective analysis
AFR Batista, D Petty, C Fairhurst, S Davies - Journal of Clinical Anesthesia, 2023 - Elsevier
Study objective Determine if psoas muscle area measured in routine preoperative computed
tomography scans (CT) can be used to identify patients at increased risk of adverse …
tomography scans (CT) can be used to identify patients at increased risk of adverse …
Clinical relevance of myopenia and myosteatosis in colorectal cancer
Y Okugawa, T Kitajima, A Yamamoto… - Journal of Clinical …, 2022 - mdpi.com
Sarcopenia was initially described as a decrease in muscle mass associated with aging and
subsequently also as a consequence of underlying disease, including advanced …
subsequently also as a consequence of underlying disease, including advanced …
[HTML][HTML] Prognostic value of artificial intelligence-driven, computed tomography-based, volumetric assessment of the volume and density of muscle in patients with …
M Kim, SM Lee, IT Son, T Park… - Korean Journal of …, 2023 - ncbi.nlm.nih.gov
Objective The prognostic value of the volume and density of skeletal muscles in the
abdominal waist of patients with colon cancer remains unclear. This study aimed to …
abdominal waist of patients with colon cancer remains unclear. This study aimed to …
The impact of sarcopenia on the outcome of patients with left-sided colon and rectal cancer after curative surgery
Q Li, T An, J Wu, W Lu, Y Wang, J Li, L Yang, Y Chen… - BMC cancer, 2023 - Springer
Background The impact of sarcopenia on the outcome of patients with left-sided colon and
rectal cancer has not been exhaustively investigated. Thus, the present study was performed …
rectal cancer has not been exhaustively investigated. Thus, the present study was performed …
Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients
K Pierce, P Philips, ME Egger, CR Scoggins… - Surgery, 2024 - Elsevier
Background Sarcopenia in cancer patients has been associated with mixed postoperative
outcomes. The aim of this study was to evaluate whether the development of sarcopenia …
outcomes. The aim of this study was to evaluate whether the development of sarcopenia …
Preoperative evaluation of sarcopenia in patients with colorectal cancer: a prospective study
GD Nunes, LZ Cardenas, TM Miola… - Revista da Associação …, 2023 - SciELO Brasil
SUMMARY OBJECTIVE: Colorectal cancer is the third most diagnosed malignant neoplasm
in the world and the fourth leading cause of cancer mortality. The loss of muscle mass in …
in the world and the fourth leading cause of cancer mortality. The loss of muscle mass in …
Sarcopenia and myosteatosis as prognostic markers in patients with advanced cholangiocarcinoma undergoing palliative treatment
MS Jördens, L Wittig, L Heinrichs, V Keitel… - Journal of Clinical …, 2021 - mdpi.com
Background: Cholangiocarcinoma (CCA) represents the second most common primary liver
cancer and is characterized by a very poor outcome, but reliable prognostic markers are …
cancer and is characterized by a very poor outcome, but reliable prognostic markers are …